MMIP briefing paper: The fiscal benefits of establishing and retaining medicine manufacture in the UK

This paper highlights the factors which combine to make the UK one of the most competitive tax and fiscal frameworks globally for medicines manufacture and in the top tier of the G20. This is not widely recognised here in the UK or overseas and the purpose of this paper is to start to address this lack of awareness by setting out the UK proposition in a simple summary.

More within